sars-covid-19 - covid-19. COVID-19 Disease
Conditions
Interventions
Intervention 1: Intervention group: In addition to receiving the drug according to the national protocol, this group uses the drug under study by inhalation. The national protocol uses interferon beta
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Positive PCR test The patient is not COPD Not having acute kidney problems The patient does not have Acute liver failure 18 years and older The patient does not need ventilator therapy The patient has low respiratory capacity The patient has covide-19
Exclusion criteria
Exclusion criteria: The patient is hospitalized for less than seven days
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The patient's respiratory capacity. Timepoint: Before reading And is monitored daily during the study. Method of measurement: Encouraging spirometry device - pulse oximeter - clinical examination.;Control of the patient's pulmonary infection. Timepoint: Clinical examinations and measurements of the patient's body temperature are performed daily before the study and during the study - the patient's CT scan is taken before the start of the study and at the end of the study. Method of measurement: Clinical examinations - mercury thermometer - CT scan. | — |
Secondary
| Measure | Time frame |
|---|---|
| Compelet blood count. Timepoint: The first and last day of the study are monitored. Method of measurement: Blood sampling from the patient.;Alkaline Phosphatase. Timepoint: The first and last day of the study are monitored. Method of measurement: Blood sampling from the patient.;Urine analysis. Timepoint: The first and last day of the study are monitored. Method of measurement: Urine sampling of the patient. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHakim abiavy
Ahvaz University of Medical Sciences
Outcome results
None listed